← back to search

Krister Cromm

Humboldt-Universität zu Berlin · DE
Area of research
Nephrology · Economics and Econometrics
Research interest
Research interests include Dialysis and Renal Disease Management, Acute Kidney Injury Research, Health Systems, Economic Evaluations, Quality of Life, and Chronic Kidney Disease and Diabetes.
h-index
9
citations
708
works
54
NIH funding
primary concept
email

Recent publications

A health economic evaluation of the multinational, randomized controlled CONVINCE trial: cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysis
Kidney International 2025cited by 15position: middledoi
The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration
Kidney International 2024cited by 44position: middledoi
Using a measurement type-independent metric to compare patterns of determinants between patient-reported versus performance-based physical function in hemodialysis patients
Quality of Life Research 2024cited by 3position: middledoi
Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure
New England Journal of Medicine 2023cited by 268position: middledoi
High-Target Hemodiafiltration Convective Dose Achieved in Most Patients in a 6-Month Intermediary Analysis of the CONVINCE Randomized Controlled Trial
Kidney International Reports 2023cited by 8position: middledoi
Physical performance tasks were linked to the PROMIS physical function metric in patients undergoing hemodialysis
Journal of Clinical Epidemiology 2023cited by 7position: middledoi
CONVINCE in the context of existing evidence on haemodiafiltration
Nephrology Dialysis Transplantation 2022cited by 27position: middledoi
Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol
BMJ Open 2020cited by 66position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark Woodward · University of Technology Sydney8 papers (2020–2025)Jörgen Hegbrant · University of Michigan–Ann Arbor8 papers (2020–2025)Giovanni FM Strippoli · The University of Sydney8 papers (2020–2025)Andrew Davenport · Charité - Universitätsmedizin Berlin8 papers (2020–2025)Matthias Rose · Humboldt-Universität zu Berlin7 papers (2020–2024)Cláudia Barth · University of Oslo7 papers (2020–2024) · 7 papers (2020–2024)Peter J. Blankestijn · Target (United States)7 papers (2020–2024)Michiel L. Bots · Amsterdam Neuroscience7 papers (2020–2024) · 7 papers (2022–2025)Robin W.M. Vernooij · University Medical Center Utrecht6 papers (2020–2025)Kathrin I. Fischer · Humboldt-Universität zu Berlin6 papers (2020–2025)Carinna Hockham · UNSW Sydney3 papers (2023–2025)Gregor Liegl · Patient-Centered Outcomes Research Institute3 papers (2023–2024)Adrian Covic · Indiana University – Purdue University Indianapolis2 papers (2023–2024)G. Ardine de Wit · Utrecht University2 papers (2020–2025) · 2 papers (2023–2024)Miriam P. van der Meulen · Utrecht University1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2025–2025)